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SURGICAL ETHICS CHALLENGES
The ethics of clinical pathways and cost control
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You are the Chief of Vascular Surgery in a large com-
munity hospital that has been experiencing financial
difficulties. Your division has been cited by the Utiliza-
tion Review Committee for excessive lengths of stay in
the ICU and hospital wards. After weeks of delibera-
tions, with minimal input from surgeons, you are di-
rected by the hospital Executive Committee to imple-
ment a fast-track clinical pathway for all patients
undergoing major vascular procedures. Your staff sur-
geons believe that the data suggesting excessive lengths
of stay are flawed and that the new directive may
significantly increase postoperative morbidity and mor-
tality. Your most responsible ethical action is which of
the following?
A. Resign from the hospital staff.
B. Direct your surgeons to implement the administration’s
policy.
C. Inform the administration that you consider fast-track-
ing unethical and will not cooperate.
D. Insist that the mandated fast-track policy be rewritten
with input of vascular surgeons.
E. Leak the story to the press.
Like physicians in all specialties, surgeons are increas-
ingly answerable for the cost of patient care. Demand for
accountability comes from many of the most powerful
blocs in our society, including government and insurance
interests, who are responding to evidence of resurging
increases in the cost of care. Private payers are trying to
control costs to remain profitable and competitive. Public
payers, such as Medicare and Medicaid, are responding to
determined resistance to additional taxes.
Most surgeons believe that their responsibility to prac-
tice medicine economically is becoming secondary to their
responsibility to practice medicine effectively.1 Surgeons
can take no satisfaction from minimizing hospital costs if
they have done so by minimizing the quality of patient care.
The virtue of integrity informs our professional standards of
moral and intellectual excellence and ethically compels us
to be guided in our decisions by clinical evidence.2 This
means attention to clinical outcome as well as to clinical
process.
The Clinical Pathways program originated as a quality
improvement process with the developing of disease-spe-
cific algorithms. These algorithms are designed to promote
standardization of diagnostic and therapeutic procedures
and limit the kinds of variations that have historically been
associated with errors, complications, and longer hospital
and ICU stays, leading to higher per-patient costs. Clinical
Pathways were intended to ensure that patients are treated
in an efficient manner with methods long established as
effective for particular conditions. Pathways were also de-
signed to discourage expensive and potentially dangerous
idiosyncratic forays off the beaten track by overly adventur-
ous individual practitioners. Despite these many virtues, the
Clinical Pathways program has sometimes found itself cal-
cified into a rigid fast-track system designed to cut costs by
mandating rapid hospital discharge once each step in the
Pathways process has been implemented. Advocates claim
quality improvement by citing early discharge as evidence
of rapid recovery, but often without reference to whether
some patients should be discharged when they are. Though
Fast Tracking is sometimes effective in reducing such sig-
nificant complications as nosocomial pneumonia, and some
patients are delighted to return home earlier, the clinical
response of all patients to the Clinical Pathways–Fast Track
process is not equivalent, and for a few, early discharge is
frightening, and even dangerous. Surgeons ethically must
be instrumental in the design, practice, and surveillance of
fast tracking; it is an important part of the surgical care
responsibility.
Evidence-based surgery evaluates clinical care compre-
hensively, studying the outcomes as well as the processes of
treatment. Neither measure alone yields comprehensive
clinical information, and neither measure alone will ensure
that the hospital will remain financially solvent and pre-
pared to treat future patients. The claim that these vascular
surgery patients have excessive lengths of stay is based on a
process measure which has not been informed by the
context of clinical outcome. Worse still, it ignores such
other process measures as severity, procedural complexity,
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comorbidities, and individual patient histories. Isolating a
process of care as a goal of care, and overlooking the health
of the patient as the goal of care, will likely be a fast route to
the hospital’s financial demise as well as the patient’s.
Concentration first upon clinical outcome and then clinical
processes to achieve the primary goal honors the hospital’s
legitimate concern for financial strength because it sub-
sumes it; the healthiest possible patients have fewer com-
plications, will be the least expensive to treat, will refer
friends and family, file fewer tort claims, and return for
additional episodes of care when the need arises.
Choice A, resigning your hospital position to protest
the mandatory fast-track policy, is precipitous. It displays an
abundance of personal rigidity, an unwillingness to nego-
tiate in good faith, and ultimately deprives needy patients
and the hospital which sustains your community of your
rare and valuable services. It violates the virtues of courage
and fortitude.
By selecting choice B and directing your surgical staff to
accept and implement the mandatory fast-track policy, you
abrogate your responsibility to patients to see that their care
is your primary professional goal. You also fail in your
leadership role as the division chief by not making your
professional staff’s clinical concerns important to the hos-
pital administration. Although it is not inherently unethical
to support your administration’s efforts to contain costs
and ensure the hospital’s function within the community, it
is inconsistent with your role as an ethical surgeon to
knowingly do so at the expense of good clinical care.
Although fast-tracking may be entirely consistent with
good care for many patients, its mandatory implementation
for all patients will certainly deprive some who respond
more slowly or encounter postoperative complications of
essential inpatient services. Choice C is inappropriate be-
cause the clinical pathways fast-track model is not in and of
itself unethical; it becomes so only when it is indiscrimi-
nately applied as a cost-saving measure without regard to
each patient’s individual clinical response.
Choice D, insisting that the administration renegotiate
the fast-track policy with significant input from the vascular
surgeons whose patients it affects, is the most clinically and
ethically responsible position. This provides the profes-
sional staff with an opportunity to educate the administra-
tors about significant clinical consequences of their ill-
advised decision, to assume the surgeon’s proper ethical
role as patient fiduciary, and to provide the hospital with a
defensible policy for containing costs in appropriate cases
while continuing to serve the legitimate health-care inter-
ests of patients.
Choice E, taking the issue to the press, virtually ensures
that any subsequent negotiations between the surgeons
and the administration will be acrimonious, defensive, and
based more in a desire to preserve reputations and image
than in guaranteeing good care. It is furthermore likely that
a complex issue will be reduced to fit a headline and thereby
distorted. Most importantly, a misunderstanding of meth-
ods among people of mutual good will and common mo-
tives is likely to be mischaracterized as a morality tale, and
the public’s trust in your local hospital seriously damaged.
In that event, financial ruin will become more likely, there
will be one less place to practice high-quality surgery, and
the entire community will suffer.
This case presents an ethical obligation frequently dis-
regarded by surgeons. The vascular surgeons should have
been attentive and proactive concerning cost control much
earlier. It is common for hospital management to issue
edicts affecting surgical practice through committees hav-
ing minimal surgical participation. It is a preventative eth-
ical duty for surgeons to interact organizationally outside
the operating room in matters of this sort. Externally
imposed policies and procedures usually occur after re-
peated attempts to overcome appeals to professional auton-
omy and the resistance to change and accountability that
such appeals often generate. Professional autonomy should
never be the fundamental ethical concern of physicians in
response to cost control; assumption of cofiduciary respon-
sibility, in the absence of which professional autonomy is
stripped of its moral authority, should be.
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